miRagen Therapeutics (NASDAQ: MGEN) is harnessing the power of microRNA science to develop therapies that normalize biological pathways and counterbalance disease.
Headquarters | Boulder, CO |
Website | www.miragen.com |
@miRagenRx | |
Pipeline | Phase 1 clinical trials |
Partners | Servier |